N-Telopeptide, Cross-Linked, Urine NTX
Method(s) | Quantitative Chemiluminescent Immunoassay | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Specimen Required | |||||||||||||||||||||||||
Collect | Urine: 2nd void of the morning or 24 hour collection, refrigerate during collection. Collect without preservative. |
||||||||||||||||||||||||
Transport | 1 mL aliquot from a well-mixed, second-morning void or 24-hour collection, frozen. (Min: 0.5 mL) |
||||||||||||||||||||||||
Stability | Ambient: 24 hours; Refrigerated: 1 week; Frozen: 4 weeks |
||||||||||||||||||||||||
Unacceptable Conditions | Samples contaminated with blood or with extensive hemolysis. |
||||||||||||||||||||||||
Schedule | Tue-Sat | ||||||||||||||||||||||||
Billing Code | 5010127 | ||||||||||||||||||||||||
CPTCode | 82523 | ||||||||||||||||||||||||
Notes | For monitoring therapy, a baseline sample should be collected prior to initiation of therapy. Subsequent samples for comparison should be collected at the same time of day as the baseline sample. | ||||||||||||||||||||||||
Preferred Specimen Collection Device(s) | |||||||||||||||||||||||||
Reference Interval | |||||||||||||||||||||||||
|